We are live on ! Find out more
BSX icon

Boston Scientific

1,512 hedge funds and large institutions have $120B invested in Boston Scientific in 2024 Q4 according to their latest regulatory filings, with 218 funds opening new positions, 617 increasing their positions, 489 reducing their positions, and 83 closing their positions.

New
Increased
Maintained
Reduced
Closed

163% more first-time investments, than exits

New positions opened: 218 | Existing positions closed: 83

26% more repeat investments, than reductions

Existing positions increased: 617 | Existing positions reduced: 489

9% more capital invested

Capital invested by funds: $111B → $120B (+$9.45B)

8% more funds holding

Funds holding: 1,3951,512 (+117)

8% more funds holding in top 10

Funds holding in top 10: 3639 (+3)

1.08% more ownership

Funds ownership: 89.89%90.98% (+1.1%)

13% less call options, than puts

Call options by funds: $797M | Put options by funds: $912M

Holders
1,512
Holders Change
+117
Holders Change %
+8.39%
% of All Funds
19.92%
Holding in Top 10
39
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+8.33%
% of All Funds
0.51%
New
218
Increased
617
Reduced
489
Closed
83
Calls
$797M
Puts
$912M
Net Calls
-$115M
Net Calls Change
+$168M
Name Holding Trade Value Shares
Change
Change in
Stake
JCM
326
Jag Capital Management
Missouri
$15.2M -$11.6M -131,254 -44%
SOADOR
327
State of Alaska Department of Revenue
Alaska
$15M -$892K -10,135 -6%
Rafferty Asset Management
328
Rafferty Asset Management
New York
$14.9M +$1.57M +17,781 +12%
JF
329
Jump Financial
Illinois
$14.7M -$10.7M -121,091 -42%
VPIM
330
Vanguard Personalized Indexing Management
California
$14.7M +$797K +9,057 +6%
ACM
331
Aquatic Capital Management
Illinois
$14.6M +$925K +10,510 +7%
BA
332
Bridgewater Associates
Connecticut
$14.6M -$17.1M -193,851 -54%
Squarepoint
333
Squarepoint
New York
$14.5M -$16.7M -189,869 -54%
AF
334
Avanza Fonder
Sweden
$14.4M +$14.2M +161,371 New
SCI
335
S&CO Inc
Massachusetts
$14.4M -$132K -1,500 -0.9%
SC
336
SouthState Corp
Florida
$14.4M +$262K +2,977 +2%
BAMCO Inc
337
BAMCO Inc
New York
$14.2M
FC
338
FACT Capital
New York
$14.2M -$1.9M -21,567 -12%
CWM
339
Calamos Wealth Management
Illinois
$13.9M +$76.8K +872 +0.6%
HP
340
HealthInvest Partners
Sweden
$13.8M +$4.23M +48,050 +45%
SCM
341
Shelton Capital Management
Colorado
$13.7M -$2.65M -30,056 -16%
SMFG
342
Sumitomo Mitsui Financial Group
Japan
$13.5M +$13.3M +150,810 New
QIM
343
Quest Investment Management
Oregon
$13.3M +$11.8M +134,237 +916%
EDRH
344
Edmond de Rothschild Holding
Switzerland
$13.3M -$6.83M -77,582 -34%
CII
345
Capital International Inc
California
$13.2M +$8.59M +97,550 +193%
Rockefeller Capital Management
346
Rockefeller Capital Management
New York
$13.2M +$890K +10,110 +7%
WF
347
Welch & Forbes
Massachusetts
$13.1M -$488K -5,547 -4%
FP
348
Financial Perspectives
Minnesota
$12.9M -$124K -1,413 -1%
DCM
349
Dupont Capital Management
Delaware
$12.8M
AIM
350
Achmea Investment Management
Netherlands
$12.5M +$5.93M +67,362 +92%

BSX Hedge Fund Activity: Q4 2024 in Review

1,512 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2024, worth a combined $120B — up 8.5% from $111B a quarter earlier.

Buyers outnumbered sellers: 218 funds opened new BSX positions and 83 closed out — a net gain of 135 holders — while 617 added to existing stakes and 489 trimmed.

The largest buyer was BlackRock, adding an estimated $909M. The largest seller was Massachusetts Financial Services, cutting an estimated $529M.

  • 1,512 institutional investors held Boston Scientific (BSX) as of Q4 2024, up from 1,395 in Q3 2024.
  • Funds reported $120B of Boston Scientific stock for Q4 2024, up 8.5% quarter-over-quarter.
  • 218 funds opened new Boston Scientific positions in Q4 2024 and 83 closed out, a net change of +135 holders.
  • The largest Boston Scientific buyer in Q4 2024 was BlackRock, an estimated $909M added.
  • The largest Boston Scientific seller in Q4 2024 was Massachusetts Financial Services, an estimated $529M sold.

Based on aggregated 13F filings for Q4 2024.